Global Molybdenum-99 (Mo-99) Market Growth 2021-2026

The global Molybdenum-99 (Mo-99) market size is predicted to grow from US$ 374 million in 2025 to US$ 503 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

Molybdenum-99 (Mo-99) is a radioactive isotope with a half-life of approximately 66 hours. It is a key precursor in the production of Technetium-99m, which is widely used in medical imaging for diagnostic purposes. Mo-99 decays into Technetium-99m through beta decay. Due to its critical role in the healthcare industry, Mo-99 is usually produced in nuclear reactors and extracted from irradiated uranium targets. The ultimate use of Technetium-99m in imaging enables detailed views of various organs and tissues, making Mo-99 essential for modern diagnostic medicine.

Global key players of X include NRG, IRE, ANSTO, NTP, Rosatom, etc. The top five players hold a share over 91%. Europe is the largest market, which has a share about 61%, followed by Australia and South Africa with a market share of 18% and 16%, respectively. In terms of product type, LEU-based is the largest segment, occupied for a share of 94%. And in terms of application, Medical Imaging is the largest segment, which has a share about 98%.

LP Information, Inc. (LPI) ' newest research report, the “Molybdenum-99 (Mo-99) Industry Forecast” looks at past sales and reviews total world Molybdenum-99 (Mo-99) sales in 2024, providing a comprehensive analysis by region and market sector of projected Molybdenum-99 (Mo-99) sales for 2025 through 2031. With Molybdenum-99 (Mo-99) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molybdenum-99 (Mo-99) industry.

This Insight Report provides a comprehensive analysis of the global Molybdenum-99 (Mo-99) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molybdenum-99 (Mo-99) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molybdenum-99 (Mo-99) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molybdenum-99 (Mo-99) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molybdenum-99 (Mo-99).

This report presents a comprehensive overview, market shares, and growth opportunities of Molybdenum-99 (Mo-99) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
LEU-based
HEU-based

Segmentation by Application:
Medical Imaging
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
NRG
IRE
ANSTO
NTP
Rosatom

Key Questions Addressed in this Report

What is the 10-year outlook for the global Molybdenum-99 (Mo-99) market?

What factors are driving Molybdenum-99 (Mo-99) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Molybdenum-99 (Mo-99) market opportunities vary by end market size?

How does Molybdenum-99 (Mo-99) break out by Type, by Application?